- Investing Ideas
- /
- Japanese Pharmaceuticals & Biotech Too Big To Fail
Japanese Pharmaceuticals & Biotech Too Big To Fail
Results
3
0 new
Large established companies which pay a dividend.
3 companies
Shionogi
Market Cap: JP¥2.3t
Researches, develops, manufactures, and distributes pharmaceuticals, diagnostic reagents, and medical devices.
4507
JP¥2,619.50
7D
-2.3%
1Y
23.7%
Ono Pharmaceutical
Market Cap: JP¥811.3b
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥1,740.50
7D
-0.3%
1Y
-8.8%
Santen Pharmaceutical
Market Cap: JP¥529.6b
Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥1,646.00
7D
-0.3%
1Y
-7.5%